Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2022 May 24;13:929770. doi: 10.3389/fimmu.2022.929770

Corrigendum: Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity

Chang Kyung Kang 1,, Minji Kim 2,3,4,, Jisu Hong 2,4,5,, Gwanghun Kim 2,3,4, Soojin Lee 2,3,4, Euijin Chang 1, Pyoeng Gyun Choe 1, Nam Joong Kim 1, Ik Soo Kim 6, Jun-Young Seo 7,8, Daesub Song 9, Dong-Sup Lee 2,3,4,10,11, Hyun Mu Shin 2,4,11, Yong-Woo Kim 11, Chang-Han Lee 2,4,5,11,*,, Wan Beom Park 1,*,, Hang-Rae Kim 2,3,4,10,11,*,, Myoung-don Oh 1
PMCID: PMC9171241  PMID: 35686133

In the original article, there was a mistake in Figure 3 as published. Figure 3D was repeatedly used instead of Figure 3F while reformatting the Figure 3 plots during the revision process. The corrected Figure 3 appears below.

Figure 3.

Figure 3

Memory B-cell responses against SARS-CoV-2 according to the severity of illness. (A, C, E) Representative gating strategy for IgM+, IgA+, and IgG+ antigen-specific memory (CD27+ CD19+) B cells. (B, D, F) Frequencies of IgM+, IgA+, and IgG+ antigen-specific memory B cells according to the severity of illness and different antigens. Statistical analysis was performed using the Kruskal–Wallis rank-sum test with Dunn’s post hoc test in GraphPad Prism (n.s.: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES